Questions? Chat with the founder on WhatsApp

Chat with the founder on WhatsApp
Arthneeti
HomeRankingsIPOScreenerInstitutions
HomeRankingsIPOScreenerInstitutions
Styrenix Perfor.Q1 FY27Chemicals & Petrochemicals
Home/Stocks/Styrenix Perfor./Q1 FY27

Styrenix Perfor. Q1 FY27 Earnings Call Analysis

Revenue, margin, capex, fundraise and order book outlook from management commentary.

Price: ₹2,087P/E: 13.4Market Cap: ₹3.7K CrSector: Chemicals & Petrochemicals

Management growth scorecard

Revenue

Category 4

Margin

Category 3

Fundraise

N/A

Order

N/A

Capex

Yes

1 of 3 growth signals are positive — mixed outlook.

Full analysis

Revenue guidance

Category 4
  • →Demand affected by volatility and geopolitical uncertainties; normalization expected to revive growth.
  • →Both auto and appliance sectors poised for growth in a normalized environment.
  • →Volume dip in Q1 FY27 attributed to non-OEM demand decline; recovery anticipated in subsequent quarters.
  • →No structural change in market channels; volumes expected to eventually catch up to end-consumer demand.
  • →Expansion projects (e.g., ABS capacity expansion) on track and expected to be completed in current financial year.
  • →New business development continues but benefits from crisis-related supply chain shifts are limited.
  • →Pricing and demand remain volatile; cautious buyer approach may delay growth rebound.
  • →Medium- to long-term strategy unchanged, focusing on growth and value-added product expansion.
  • →Overall, growth expected with normalization, but precise volume guidance withheld due to uncertainty.

Margin guidance

Category 3
  • →Expansion plans, particularly the ABS capacity expansion, are on track and expected to be completed within the financial year, which should contribute to volume growth.
  • →Volume guidance is not explicitly given due to geopolitical uncertainties; however, the company aims to sell most of the increased production capacity.
  • →Mid-term (around 3 years) margins and growth are expected to be in line with existing business margins, balancing volume growth with competitive intensity.
  • →Demand in core sectors (auto, appliances) is poised for growth, suggesting stable or improved earnings potential if the macro environment normalizes.
  • →Pricing and margin volatility persist due to raw material cost fluctuations and global uncertainties, but the company expects margins to normalize to historical levels rather than expand significantly.
  • →The company maintains a strategy focused on value-added products and operational resilience to sustain earnings growth.

3 more insights locked — sign up free to unlock

Fundraise plans

  • →The company did not mention any current or planned fundraising through debt or equity in the provided transcript.
  • →Capital allocation strategy remains consistent, focusing on judicious use of capital for growth and returning excess cash to shareholders.
  • →They have capex planned for the year, funded through internal cash flows and earnings.
  • →No incremental plans for raising funds beyond existing capital and operational cash flows were discussed.
  • →The company emphasizes maintaining capital ratios and best utilization of resources without holding excess capital unnecessarily.

Order book

  • →The order processing cycle typically ranges from 12 to 24 months, starting with small trial lots progressing to larger commercial orders.
  • →The company is committed to this phased approach with experienced teams in targeted segments.
  • →Demand in Thailand remains steady with interest in the differentiated product profile despite competitive intensity.
  • →Expansion of ABS capacity is planned for the current financial year, but the exact commissioning month is uncertain due to complexity and compliance requirements.
  • →Volume guidance is not provided due to geopolitical uncertainty and market volatility; the company expects to sell most of its produced volumes.
  • →Overall, order progress and volume realization are in line with company expectations and strategy.

Capex plans

Yes
  • →Styrenix is undertaking a brownfield expansion of its ABS plant, aiming for completion within the current financial year (FY 2026-27), though exact commissioning month is uncertain due to complexities in operating alongside running plants and prioritizing safety and environmental obligations.
  • →Expansion includes increasing capacities at all sites, covering rubber, SAN (styrene-acrylonitrile), and compounding to support the additional volume from the ABS expansion.
  • →The company is executing these capex plans with careful consideration of operational challenges in a running plant setting.
  • →No exact volume guidance or timeline for capex commissioning is provided due to geopolitical and market uncertainties.
  • →The company intends to use extra cash flow judiciously, prioritizing capex needs first, and returning surplus capital to shareholders, consistent with its earlier capital allocation philosophy.
  • →No mention of other specific strategic investments or greenfield projects at this time.

How does Styrenix Perfor. rank vs peers in Chemicals & Petrochemicals?

Pro feature
1Styrenix Perfor.
Rev 4Mar 3
2Chemicals & Petrochemicals Company A
Rev 1Mar 2
3Chemicals & Petrochemicals Company B
Rev 2Mar 1
4Chemicals & Petrochemicals Company C
Rev 2Mar 3

See full Chemicals & Petrochemicals sector rankings

How does Styrenix Perfor. rank in Chemicals & Petrochemicals?

Compare Styrenix Perfor. against every Chemicals & Petrochemicals company (Q1 FY27) on revenue, margins and earnings-call signals.

View Chemicals & Petrochemicals leaderboard →

Related research

Read the full Q1 FY27 earnings insight — Styrenix Perfor.

Other quarters — Styrenix Perfor.

Q4 FY26Q3 FY26Q2 FY26Q1 FY26Q4 FY25Q3 FY25Q2 FY25Q1 FY25Q4 FY24Q3 FY24Q2 FY24Q1 FY24

Chemicals & Petrochemicals peers

Aarti Industries · Q1 FY27BASF India · Q4 FY26Deepak Fertilis. · Q1 FY27Deepak Nitrite · Q1 FY27Himadri Special · Q1 FY27
Styrenix Perfor. full stock analysisChemicals & Petrochemicals sectorEarnings call directoryRankings dashboard

Questions about this analysis? Chat directly with the founder — real answers about the research, not a support bot.

WhatsApp the founder

Research team or advisory firm? Get earnings-call intelligence and ranking history as research inputs for your firm.

For Institutions

Arthneeti AI

AI-powered stock analysis from earnings call transcripts. Helping Indian investors make smarter decisions with data-driven insights.

Analysis

  • Stock Rankings
  • Sectors
  • Compare Stocks
  • IPO Dashboard
  • Stock Screener
  • Earnings Call Analysis
  • Stocks Under ₹500
  • Multibaggers

Tools

  • MF Overlap Checker
  • SIP Calculator
  • CAGR Calculator
  • FD vs Equity
  • All Calculators

Resources

  • Blog
  • Weekly Digest
  • Portfolio Analysis
  • Build Portfolio
  • Earnings Calendar
  • Q1 FY27 Earnings Hub

Company

  • Pricing
  • How Our Analysis Works
  • For Institutions
  • Terms of Service
  • Privacy Policy

Compare

  • vs Screener.in
  • vs Trendlyne
  • vs Tickertape
  • vs Moneycontrol Pro
+91 90841 32575 support@arthneeti.com Bengaluru, India

© 2026 Arthneeti AI. All rights reserved.

AI-analyzed data from 1,500+ company earnings calls

Continue your research

What Styrenix Perfor.'s management said in earlier quarters

  • Q1 FY27 earnings call analysis →
  • Q1 FY26 earnings call analysis →
  • Q3 FY26 earnings call analysis →
  • Q2 FY26 earnings call analysis →

Others in Chemicals & Petrochemicals this season

  • Fineotex Chemical Ltd (Q1 FY27)

    INR 1,000 crores in FY'26. Key concall takeaways from Fineotex Chemical Ltd's Q1 FY27 earnings call — and how it ranks against sector peers.

  • Tanfac Inds. (Q1 FY27)

    Around 80% to 85% of the solar grade DHF plant capacity is contracted. Key concall takeaways from Tanfac Inds.'s Q1 FY27 earnings call — and how it ranks…

  • Epigral (Q1 FY27)

    Profit after tax (PAT) grew 25% in Q1 FY27 compared to Q1 FY26, reflecting resilience despite a challenging environment. Key concall takeaways from Epigral's…

  • S H Kelkar & Company Ltd (Q1 FY27)

    15 crore). Key concall takeaways from S H Kelkar & Company Ltd's Q1 FY27 earnings call — and how it ranks against sector peers.

Compare:vs Solar Industries India Ltdvs Pidilite Inds.vs SRF